Vaccitech valued at $579m in US public offering
Company that owns the tech behind Oxford/AstraZeneca Covid vaccine raises $111m
Full Article
Vaccitech valued at $579m in US public offering
FT.com
0 shares
1 views
You might like
Related news coverage
US's global corporate tax offer, ShareChat booms, Vaccitech IPO
Start-up group confidentially files for an initial public offering
FT.com